Drug profile · INN
thioridazine hydrochloride
THIORIDAZINE HYDROCHLORIDE
thioridazine hydrochloride (THIORIDAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — thioridazine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
thioridazine hydrochloride (THIORIDAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is thioridazine hydrochloride?
thioridazine hydrochloride (THIORIDAZINE HYDROCHLORIDE) is a d2-like dopamine receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for thioridazine hydrochloride?
THIORIDAZINE HYDROCHLORIDE is a marketed brand name for thioridazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thioridazine hydrochloride?
thioridazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.